The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia
The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia
The goal of this study is to answer the following questions:
Inclusion Criteria:
Exclusion Criteria:
National City, California 91950, United States
Canton, Ohio 44708, United States
Johnson City, Tennessee 37614, United States
Memphis, Tennessee 38105, United States
DeSoto, Texas 75115, United States
Rio de Janeiro, 21020-130, Brazil
Salvador, 40301500, Brazil
Beer Yaacov, 70350, Israel
Mexico City, 14050, Mexico
Bayamón, 00961, Puerto Rico
Ponce, 00717, Puerto Rico
San Juan, 00907, Puerto Rico
San Juan, Puerto Rico
Moscow, 117603, Russia